Stoke Therapeutics Eulerpool naujienos

Stoke Therapeutics akcijų naujienos

Stoke Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Stoke Therapeutics naujienas mes pateikiame čia.

• gruodžio 5 d. ·

  Yahoo
  STOK Shares Up on FDA's Breakthrough Tag for Dravet Syndrome Drug
• gruodžio 4 d. ·

  Yahoo
  Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome
• gruodžio 2 d. ·

  Yahoo
  Stoke Therapeutics Announces Plans to Present New Data that Support Zorevunersen as Potentially the First Disease-Modifying Medicine for Dravet Syndrome at the American Epilepsy Society 2024 Annual Meeting
• lapkričio 26 d. ·

  Yahoo
  An RNA biotech draws the blueprint for a late-stage Dravet syndrome trial and beyond
• lapkričio 20 d. ·

  Yahoo
  Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
• lapkričio 8 d. ·

  Yahoo
  Wall Street Analysts Believe Stoke Therapeutics (STOK) Could Rally 66.84%: Here's is How to Trade
• lapkričio 6 d. ·

  Yahoo
  Need To Know: Analysts Are Much More Bullish On Stoke Therapeutics, Inc. (NASDAQ:STOK) Revenues
• lapkričio 1 d. ·

  Yahoo
  Fortrea Holdings Inc. (FTRE) Reports Next Week: Wall Street Expects Earnings Growth
• spalio 13 d. ·

  Yahoo
  Stoke Therapeutics assumed with an Outperform at Leerink
• spalio 12 d. ·

  Yahoo
  Stoke Therapeutics, Inc (STOK): Pioneering RNA Medicine for Genetic Diseases